Bobak R. Azamian, President/CEO and Board Chair at Tarsus Pharmaceuticals, Inc. (TARS), sold 11,443 shares at $82.41 ($944K) on 2025-12-24, disclosed to the SEC on 2025-12-30.
Scheduled sale ($944k) by President/CEO and Board Chair under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $82.41 | 5,443 | $449K | 47.5% |
| 2 | $82.41 | 5,443 | $449K | 47.5% |
| 3 | $83.54 | 557 | $47K | 4.9% |
| Total | $82.47 avg | 11,443 | $944K | 100% |
| Filing → |
| TARS | SELL | 2026-06-22 | $615K | — | Filing → |
| TARS | SELL | 2026-03-19 | $2.4M | — | Filing → |
| TARS | SELL | 2025-09-26 | $332K | — | Filing → |